Current Headlines

  1. New FISH System Reduces Probe Per Test By 75%
    4/27/2016

    SciGene recently introduced the MicroFISH Assay System, a clinically validated method combining microvolume, multiwell slides with SciGene slide processing instruments to economically perform routine cellular FISH in cytogenetic laboratories.

  2. Meissner To Exhibit At INTERPHEX In New York
    4/26/2016

    Meissner will be exhibiting at INTERPHEX New York, in New York City, NY, during the week of April 25, 2016. Meissner will be hosting visitors in booth #2341 from April 26 – 28, at the Jacob Javits Convention Center, during the event.

  3. Astellas Announces Key Leadership Appointments
    4/25/2016

    Astellas today announced key leadership appointments in its Ethics and Compliance and US Legal departments, taking effect April 25.

  4. Amgen To Participate In World Medical Innovation Forum On Cancer
    4/25/2016

    Amgen (NASDAQ: AMGN) today announced plans to participate in the World Medical Innovation Forum™ on cancer held April 25-27, 2016, in Boston.

  5. Sangamo BioSciences Announces Presentations On ZFP Therapeutic Programs
    4/20/2016

    Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announced that data from several ZFP Therapeutic programs will be presented at the 19th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) to be held in Washington, D.C. from May 4-7, 2016.

  6. Lpath Reports Favorable Results From Phase 1 Study Of Lpathomab
    4/19/2016

    Lpath, Inc. (NASDAQ: LPTN), the industry leader in bioactive lipid-targeted therapeutics, announced today completion of its Phase 1 double-blind, placebo-controlled, single ascending dose study to evaluate the safety, tolerability, immunogenicity and pharmacokinetics of Lpathomab™ in healthy volunteers.

  7. JSR Corp. Establishes JSR Life Sciences Division, Names Leader
    4/18/2016

    JSR Corporation recently announced the formation and establishment of its Life Sciences Division, JSR Life Sciences (JLS). The newly formed JLS has been established as a business unit for parent company, Tokyo-based JSR Corporation, a company with more than 50 years of success in material and polymer chemistries including marketing latex and magnetic beads to life sciences and diagnostic companies worldwide.

  8. British Biosimilars Association (BBA) Launches In UK
    4/18/2016

    A new industry body, the British Biosimilars Association (BBA), has been formally launched recently with the sole focus of increasing the understanding and use of biosimilar medicines in the UK.

  9. WuXi AppTec Acquires Crelux
    4/15/2016

    WuXi AppTec, a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, today announced that it has acquired Crelux GmbH, a leading structure based drug discovery provider based in Munich, Germany.

  10. CSafe Continues Global Growth Initiative With New Company In Puerto Rico
    4/14/2016

    CSafe Global forms a new company, opens a new Service Center and welcomes a new Director of Sales in one of the world's foremost pharma production locations.